10.4% growth in sales the first nine months of 2008

2008 earnings goal confirmed/

--------------------------------------------------------------------------------
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
the content of this announcement.
--------------------------------------------------------------------------------

balance/9-Month Report 2008

Berlin (euro adhoc) - Sales of medical device manufacturer WORLD OF
MEDICINE grew in the first nine months of 2008 by 10.4% to
TEUR27,769. Pre-tax sales yield equaled last year's figure of 15.6%.
"The Company is positioned within the corridor that will enable us to
achieve the earnings goal for 2008: A pre-tax sales yield of 11%,"
says Peter P. Wiest, CEO. "However, we are seeing signs of a further
slowdown, particularly in the US market, due to the current financial
crisis. In view of the consequent risks to projected growth and to
our business, we currently anticipate that the Group will fall
slightly short of the 2008 sales target - an increase equal to 7%."
For the medium term, WORLD OF MEDICINE has firmly secured its
position as the global market leader in a significant area of
Minimally Invasive Surgery through strategically important projects
and a global agreement with a US-based major customer.

Earnings per share in the first nine months of 2008 equaled EUR 0.34.
Last year,one-time proceeds from the sale of the former subsidiary,
IB Laser, were reported.

| |9M/2008 |9M/2007 |Change
||Sales |TEUR27,769 |TEUR25,142 |+ 10.4% |
|EBT |TEUR4,323 |TEUR3,927 |+ 10.1% |
|Pre-tax sales yield|15.6% |15.6% |+/- 0 % |
|Earnings per share |EUR 0.34 |EUR 0.54 |- 37.0%
(adjusted for |
| | |one-time effect
on income: EUR 0.43) |
|

The entire Quarterly Financial Report for the first 9 months of 2008
is available at:

www.world-of-medicine.com/wsc/pdf/wom/en/qr_9monthreport_2008_wom.pdf

WORLD OF MEDICINE and its technologies are paving the way in
Minimally Invasive Surgery - or MIS for short. This approach includes
safe and gentle surgical procedures conducted through keyhole or
puncture incisions, in place of major incisions. The Company is the
global market leader in a niche of this future market.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: W.O.M. WORLD OF MEDICINE AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Stefanie Gehrke

Tel.: +49 (0)30 399 81 566

E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade